Complicating matters further, PACAP can penetrate the blood-brain barrier via transporters, potentially influencing the central nervous system, thereby confounding efforts to isolate its effects on peripheral neuropathy [65]. Here, ADCYAP1 is linked to peripheral neuropathy.